Virginia 2023 Regular Session

Virginia House Bill HJR544

Introduced
1/11/23  

Caption

Alzheimer's Disease; Joint Commission on Health, etc., to study treatment.

Impact

The passage of HJR544 has the potential to influence state healthcare policies significantly, particularly in terms of treatment options for Alzheimer's patients and the training of healthcare professionals. By outlining specific areas for investigation, such as insurance coverage for diagnostic tools and therapeutics, the bill seeks to address gaps in care and reduce the financial and emotional burden on caregivers. The anticipation is that the findings could lead to enhanced public health measures and improved access to necessary healthcare services, thus positively impacting the quality of life for those affected by Alzheimer's.

Summary

HJR544 is a resolution that directs the Joint Commission on Health Care and the Alzheimer's Disease and Related Disorders Commission to conduct a comprehensive study on the treatment of Alzheimer's disease in Virginia. The aim of the study is to analyze various aspects of Alzheimer's treatment including continuing medical education for healthcare providers, public health education strategies for both patients and caregivers, and the inclusion of advanced treatment options within the Commonwealth's Alzheimer's plans. This resolution recognizes the substantial impact Alzheimer's has on the lives of approximately 150,000 Virginia residents aged over 65, highlighting the need for effective treatment strategies and support systems.

Contention

While the resolution has garnered support due to its focus on healthcare improvements, there is an underlying concern regarding the comprehensive nature of the study and whether it would adequately address the urgent needs of Alzheimer's patients and their families. Critics could argue that studying the issue is merely a way to delay action, and there may be calls for immediate legislative changes or increased funding for Alzheimer’s treatment and caregiver support. Thus, the resolution marks a critical first step, but its effectiveness ultimately hinges on the subsequent actions taken by the General Assembly based on the study's recommendations.

Companion Bills

No companion bills found.

Previously Filed As

VA HJR60

Sickle cell disease; Joint Commission on Health Care to study.

VA SJR11

Eating disorders; Joint Commission on Health Care to study.

VA SB952

Alzheimer's Disease and Related Disorders Commission; membership, sunset.

VA HJR464

Cardiovascular disease screening coverage; Health Insurance Reform Commission to study.

VA HB910

Relating To Rare Diseases.

VA SJR14

Commonwealth's public health system; Joint Commission on Health Care to study.

VA HJR41

Fentanyl crisis; Joint Commission on Health Care to study policy solutions.

VA HB933

Alzheimer's disease and dementia; training for dispatchers, firefighters, etc.

VA HJR535

Life expectancy; Joint Commission on Technology and Science to study differences in Virginia, etc.

VA S1242

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

Similar Bills

AZ SB1539

Alzheimer's; dementia; advisory council

AZ SB1199

Alzheimer's; dementia; advisory council.

HI HB278

Relating To Health.

NJ S2665

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S1242

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A2924

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

HI HB322

Relating To Health.

HI HB322

Relating To Health.